Works cited by this work

189 works

Work: Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Marina Colombo, Graça Raposo, Clotilde Théry
Review article201412 citations
ABI
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
Review article20127 citations
ABI
Extracellular vesicles: Exosomes, microvesicles, and friends
Graça Raposo, Willem Stoorvogel
Review article20135 citations
ABI
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin +20
Article20194 citations
ABI
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
Wenyan Fu, Changhai Lei, Shuowu Liu +12
Article20194 citations
ABI
Delivery technologies for cancer immunotherapy
Rachel Riley, Carl H. June, Róbert Langer +1
Review article20193 citations
ABI
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Philip W. Kantoff, Celestia S. Higano, Neal D. Shore +10
Article20103 citations
ABI
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp, Michael Kalos, David M. Barrett +10
Article20133 citations
ABI
CTLA-4 and PD-1 Pathways
Elizabeth I. Buchbinder, Anupam M. Desai
Review article20153 citations
ABI
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dai Fukumura, Jonas Kloepper, Zohreh Amoozgar +2
Review article20183 citations
ABI
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo, Brian Ruffell
Review article20193 citations
ABI
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Ju‐Yeun Lee, Hyun Tae Lee, Woo‐Ri Shin +11
Article20162 citations
ABI
Going viral with cancer immunotherapy
Brian D. Lichty, Caroline J. Breitbach, David F. Stojdl +1
Review article20142 citations
ABI
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach, Rozanne Arulanandam, Naomi De Silva +15
Article20132 citations
ABI
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio +26
Article20152 citations
ABI
Viral vectors: a look back and ahead on gene transfer technology.
Laura Vannucci, Michele Lai, Flavia Chiuppesi +2
Article20132 citations
ABI
Untitled
Other2 citations
ABI
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal +3
Review article20192 citations
ABI
Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold
Thanh Loc Nguyen, Bong Geun, Young‐Jin Choi +2
Article20202 citations
ABI
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen, Ira Mellman
Review article20132 citations
ABI
Cancer immunotherapy comes of age
Ira Mellman, George Coukos, Glenn Dranoff
Review article20112 citations
ABI
The future of immune checkpoint therapy
Padmanee Sharma, James P. Allison
Review article20152 citations
ABI
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei‐Hwei Chang, San‐Lin You, Chien‐Jen Chen +9
Article20092 citations
ABI
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi, Siok‐Keen Tey, Gianpietro Dotti +17
Article20112 citations
ABI
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
G. Fyfe, Richard I. Fisher, S A Rosenberg +3
Article19952 citations
ABI